This was reported in experimental rat models of PAH, with reduced BMPR2 and inflammation (18) and with senescence induced by an aortocaval shunt and monocrotaline, and validated in human tissue from patients with PAH by elevated survivin expression (20). Here, BIRC5 is linked to pulmonary arterial hypertension.